GSK Investigational Site

Santiago 15705

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus Infections

Studies at this site

• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers — Withdrawn before enrolling